AI処方箋コンプライアンスツール

家

AIプロンプト一覧

医療健康

処方箋審査アシスタント

${:__('collect %s',処方箋審査アシスタント)}$

医療健康

臨床ガイドラインに基づき処方箋の妥当性を自動審査し、潜在的な薬物相互作用や禁忌を特定し、標準化された審査レポートを生成します。

プロンプト内容

コピー

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract the drug name, dosage, route of administration, and frequency from the prescription, and cross-reference them with the patient's diagnosis, allergy history, and liver/kidney function indicators. Focus on identifying incompatibilities, overdosage, or violations of administration time windows. If potential risks are found, provide specific adjustment suggestions or alternative plans based on the latest clinical medication guidelines, along with the rationale. Finally, generate a structured audit summary listing all potential risk points and corresponding handling suggestions to ensure medication safety and adherence to medical standards.

コピー

熟練した臨床薬剤師として、提供された患者の処方箋が規則に準拠しているか審査してください。まず、処方箋から薬剤名、用量、投与経路、頻度を抽出し、患者の診断、アレルギー歴、肝腎機能指標と照合します。互換性の欠如、過量投与、または投与時間枠の違反がないか重点的に確認します。潜在的なリスクが見つかった場合は、最新の臨床投薬ガイドラインに基づき、具体的な調整提案または代替案とその理由を提供してください。最後に、すべての潜在的なリスクポイントと対応する処理提案をリストアップした構造化された審査サマリーを生成し、医薬品の安全性と医療基準の遵守を確保してください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方箋審査アシスタント

Act as a senior clinical pharmacist to conduct a deep compliance review of the provided patient prescription data. First, extract the patient's age, gender, weight, liver and kidney function indicators, and current medication list. Second, based on the latest clinical guidelines, analyze the interaction risks between newly prescribed drugs and existing medications, focusing on contraindications, dosage limits, and administration route appropriateness. Finally, if any potential risks are identified, clearly specify the conflict points and provide evidence-based alternative solutions or adjustment recommendations to ensure the output is clear, professional, and directly supports clinical decision-making.

処方審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to identify potential risks and output a structured report including risk level, specific rationale, and adjustment recommendations to ensure patient medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists including dosage, frequency, and route. Second, based on the latest clinical guidelines and package inserts, check for drug-drug interactions, contraindications, and dosage adjustments for special populations such as those with hepatic or renal impairment. Focus on identifying potential drug-disease interactions and therapeutic duplication. Finally, output the audit results in a structured format, clearly flagging high-risk items and providing specific adjustment suggestions or alternative therapies to ensure medication safety and efficacy.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness. Identify any risk points according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations to ensure patient medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist. Based on the provided patient demographics, medical history, and the list of medications to be prescribed, perform a prescription appropriateness review. Focus on analyzing drug-drug interactions, dosage appropriateness, and contraindications. Provide clear safety recommendations or adjustment plans based on the latest clinical guidelines to ensure patient medication safety.

処方審査アシスタント

Act as a senior clinical pharmacist and review the following prescription according to the latest clinical medication guidelines: The patient is a 65-year-old male diagnosed with type 2 diabetes and mild renal insufficiency (eGFR 45ml/min). The current prescription includes metformin, glimepiride, and aspirin. Focus on evaluating the necessity of dose adjustment for metformin in the context of renal insufficiency, analyze the hypoglycemia risk associated with glimepiride, and check for potential interactions between aspirin and anticoagulants. Finally, provide specific dosage adjustment recommendations or alternative drug suggestions to ensure the safety and efficacy of the medication regimen.